✦ LIBER ✦

Pharmacokinetic/Pharmacodynamic and Time-to-Event Models of Ribavirin-Induced Anaemia in Chronic Hepatitis C

✍ Scribed by Dr Michel Tod, Muriel Farcy-Afif, Jeanick Stocco, Nathalie Boyer, Valérie Bouton, Martine Sinégre, Patrick Marcellin

Book ID: 119926633
Publisher: Springer International Publishing AG
Year: 2005
Tongue: English
Weight: 342 KB
Volume: 44
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200544040-00006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ribavirin dosing in chronic hepatitis C:

Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic-pharmacodynamic models

✍ JEN, J; LAUGHLIN, M; CHUNG, C; HEFT, S; AFFRIME, M; GUPTA, S; GLUE, P; HAJIAN, G 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

Population Pharmacokinetics and Pharmaco

Population Pharmacokinetics and Pharmacodynamics of Ribavirin in Patients with Chronic Hepatitis C Genotype 1 Infection

✍ Jin, Runyan; Fossler, Michael J.; McHutchison, John G.; Howell, Charles D.; Dowl 📂 Article 📅 2012 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 437 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Peginterferon and Ribavirin: Implications for Clinical Efficacy in the Treatment of Chronic Hepatitis C

✍ Noureddin, Mazen; Ghany, Marc G. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Association of host pharmacodynamic effe

Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C

✍ Raymond T. Chung; Fred F. Poordad; Tarek Hassanein; Xiaolei Zhou; Ellen Lentz; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB

Patients receiving therapy for chronic hepatitis C virus (HCV) infection frequently experience cytopenias and weight loss. We retrospectively assessed the pharmacodynamic effects of pegylated interferon (PEG-IFN) alfa-2a and ribavirin by evaluating the relationship between changes in hematologic par

253 ASSOCIATION OF HOST PHARMACODYNAMIC

253 ASSOCIATION OF HOST PHARMACODYNAMIC EFFECTS AND VIROLOGIC RESPONSE TO PEGINTERFERON ALFA-2A/RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C

✍ R.T. Chung; A. Di Bisceglie; F.F. Poordad; T. Hassanein; X. Zhou; E. Lentz; A. P 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB

T1979 Association of Host Pharmacodynami

T1979 Association of Host Pharmacodynamic Effects and Virologic Response to Peginterferon Alfa-2a/Ribavirin in Patients With Chronic Hepatitis C

✍ Chung, Raymond T.; Di Bisceglie, Adrian M.; Poordad, Fred; Hassanein, Tarek; Zho 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 199 KB